Browsing Category
Pharma Industry News
4747 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Blueprint Medicines highlights long-term clinical and real-world data for Ayvakit at EHA and EAACI 2025
Blueprint Medicines presents strong long-term survival and safety data for Ayvakit in systemic mastocytosis at EHA and EAACI 2025. Explore the clinical and market impact.
Enliven Therapeutics’ ELVN-001 shows strong Phase 1 results in CML, with Phase 3 plans in 2026
ELVN-001 from Enliven Therapeutics shows 47% MMR in CML trial; see what this means for the stock outlook and future Phase 3 plans. Read more.
Astellas Pharma and MRI partner to accelerate global expansion of Japanese drug discovery startups
Astellas Pharma and Mitsubishi Research Institute partner to accelerate Japan’s drug discovery startups under MEDISO, offering global access and lab support.
PharmaResearch spin-off approved: Strategic realignment to create holding and operating firms by November 2025
PharmaResearch to restructure into holding and operating entities by Nov 2025, aiming to sharpen focus and boost global competitiveness. Read full analysis.
BioArctic advances exidavnemab phase 2a cohorts after safety review
BioArctic expands its Phase 2a trial for exidavnemab after a successful safety review. Read how this impacts Parkinson’s and MSA drug development today.
Keymed Biosciences’ CM336 shows sustained remission in AIHA patients after CAR-T failure
Keymed Biosciences’ CM336 delivers 6-month remission in AIHA post-CAR-T failure, with NEJM publication and bullish stock sentiment. Find out what’s next for the biotech.
Sigachi Industries (NSE: SIGACHI) secures SEIAA nod for Orvakal API project
Sigachi Industries gets SEIAA approval for its Orvakal API and specialty chemicals facility. Environmental clearance starts July 15. Read how this expansion reshapes growth.
The oral biologics revolution: How macrocyclic peptides could reshape drug delivery
Macrocyclic peptides are revolutionizing oral biologics. Explore how Merck, Protagonist, and others are turning injectables into convenient, high-impact pills.
CureVac stock surges as BioNTech announces strategic mRNA-focused acquisition
BioNTech acquires CureVac in a $1.25B all-stock deal to expand its mRNA cancer pipeline. Includes stock insights, premium terms, and investor sentiment.
Deep Apple Therapeutics signs $812m global deal with Novo Nordisk for oral cardiometabolic drugs
Deep Apple inks up to $812M deal with Novo Nordisk to advance oral GPCR drugs for obesity and metabolic diseases. Explore the science behind the strategy.